Northwestern University researchers have taken another step towards realizing a new class of polymerase chain reaction enzyme mimics, opening the door for the development of highly sensitive chemical detection systems that go beyond nucleic acid targets.
Drug companies have not only sponsored the science of a new condition known as female sexual dysfunction, they have helped to construct it, in order to build global markets for new drugs.
Research ethics review committees often require all women of childbearing age who enroll in clinical trials to use contraceptives to protect against a developing fetus being exposed to potentially harmful drugs.
The new health care law could make it difficult for companies like McDonald's to continue offering limited insurance coverage to their low-wage workers.
Johnson & Johnson executives and the Food and Drug Administration both shouldered the blame for a secret recall in which hired contractors quietly bought up defective painkillers to clear them from store shelves.
Walgreen Co. said it will begin selling special envelopes to shoppers to help them dispose of medications they no longer need.
Drugmaker Merck & Co. plans to appeal a federal court verdict that a former subsidiary caused the commonwealth of Massachusetts to overpay pharmacists for a widely used asthma medication, the company said.
Novartis Pharmaceuticals Corp. will pay $422.5 million in penalties for marketing an epilepsy medicine for unapproved uses and for paying kickbacks to doctors to prescribe it and five other drugs, federal officials announced.
Crescendo Biologics Limited has established a colony of engineered mice completely devoid of endogenous antibody polypeptides. The mice are believed to have the immunoglobulin heavy chain, kappa light chain, and lambda light chain loci all functionally silenced.
caprotec bioanalytics GmbH announced the commercial launch of three new caproKits, enabling the discovery, identification and characterization of proteins for applications in functional proteomics and drug development.
Covance Inc. announced the expansion of its biotechnology offerings into North America with the opening of a biotechnology services facility on its Greenfield campus in Indiana.
DaVita Clinical Research has announced the launch of its clinical central lab facility. The over-47,000 square foot facility allows technicians to perform approximately 114,000 tests on 60,000 samples daily.
Synosia Therapeutics announced the first clinical study results showing that SYN-118 provides clinically meaningful benefits to Parkinson’s patients, has a good safety profile and is well tolerated.
In recent human trials for a promising new class of drug designed to target the hepatitis C virus without shutting down the immune system, some of the HCV strains being treated exhibited signs of drug resistance.
Researchers at the Indiana University Melvin and Bren Simon Cancer Center have published the first report using imaging to show that changes in brain tissue can occur in breast cancer patients undergoing chemotherapy.